Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Tim Rickeard, Eileen Gallagher, Charlotte Gower, Meaghan Kall, Natalie Groves, Anne-Marie O’Connell, David Simons, Paula B. Blomquist, Asad Zaidi, Sophie Nash, Nurin Iwani Binti Abdul Aziz, Simon Thelwall, Gavin Dabrera, Richard Myers, Gayatri Amirthalingam, Saheer Gharbia, Jeffrey C. Barrett, Richard Elson, Shamez N Ladhani, Neil Ferguson, Maria Zambon, Colin NJ Campbell, Kevin Brown, Susan Hopkins, Meera Chand, Mary Ramsay, Jamie Lopez Bernal
doi: https://doi.org/10.1101/2021.12.14.21267615

Data Availability

Data cannot be made publicly available for ethical and legal reasons, i.e. public availability would compromise patient confidentiality as data tables list single counts of individuals rather than aggregated

Back to top
Posted December 14, 2021.
Download PDF
Data/Code
Email
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Tim Rickeard, Eileen Gallagher, Charlotte Gower, Meaghan Kall, Natalie Groves, Anne-Marie O’Connell, David Simons, Paula B. Blomquist, Asad Zaidi, Sophie Nash, Nurin Iwani Binti Abdul Aziz, Simon Thelwall, Gavin Dabrera, Richard Myers, Gayatri Amirthalingam, Saheer Gharbia, Jeffrey C. Barrett, Richard Elson, Shamez N Ladhani, Neil Ferguson, Maria Zambon, Colin NJ Campbell, Kevin Brown, Susan Hopkins, Meera Chand, Mary Ramsay, Jamie Lopez Bernal
medRxiv 2021.12.14.21267615; doi: https://doi.org/10.1101/2021.12.14.21267615
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area